Catalyst Wire Dossier Catalyst Wire Dossier

GEMOX regimen

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GEMOX regimen, covering 2019-12-09 to 2019-12-09. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study on the First-line Treatment of Advanced Biliary System Tumors With Tripley Monoclonal Antibody Combined With GEMOX Regimen [Phase 2]

See pricing